2015
DOI: 10.1016/j.ejmech.2014.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
38
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 89 publications
(41 citation statements)
references
References 55 publications
(56 reference statements)
2
38
0
Order By: Relevance
“…Synthesis of 5-Bromo-3-hydrazonoindolin-2-one To a stirred solution of 5-bromoisatin (2.26 g, 10 mmol) in methanol (20 mL), 99% hydrazine hydrate (2.5 mL, 50 mmol) was added. The reaction mixture was refluxed for 1 h. The precipitate was filtered, washed with methanol, and dried to afford 5-bromo-3-hydrazonoindolin-2-one [28] in almost quantitative yield.…”
Section: Chemistrymentioning
confidence: 99%
“…Synthesis of 5-Bromo-3-hydrazonoindolin-2-one To a stirred solution of 5-bromoisatin (2.26 g, 10 mmol) in methanol (20 mL), 99% hydrazine hydrate (2.5 mL, 50 mmol) was added. The reaction mixture was refluxed for 1 h. The precipitate was filtered, washed with methanol, and dried to afford 5-bromo-3-hydrazonoindolin-2-one [28] in almost quantitative yield.…”
Section: Chemistrymentioning
confidence: 99%
“…In 2015, Eldehna et al [44] synthesized certain isatin-pyridine hybrids as potential anti-proliferative agents, four of these compounds 24a-d are 3-hydrazino-2-indolinone derivatives (Figure 15). Compounds 24b and 24c showed good activity against HepG2 cancer cell line with IC 50 = 11.5 and 8.7 µM, respectively.…”
Section: Figure 15mentioning
confidence: 99%
“…Regarding these points and as a continuation of our research program on the design and synthesis of effective antitumor candidates [29,30,31,32,33,34,35], it was thought worthwhile to extend our investigations around our study [28] to probe for benzimidazole derivatives having anti-proliferative activity towards TNBC. Our structure-based design was three-fold: (i) preserving benzimidazole structure with subsitution at 2-position; (ii) maintaining a terminal lipophilic group; and (iii) establishing a three-atom thio ethane-1-one linker to afford more flexibility for the designed molecules (Figure 2).…”
Section: Introductionmentioning
confidence: 99%